Osteoporosis prevention and treatment: its relevance to breast cancer patients.
"Osteoporosis is a systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility." This particular definition of osteoporosis was proposed at the Fourth International Symposium on Osteoporosis (Consensus Conference) in Hong Kong in April 1993; it attempts to combine the description of low bone mass with the risk for consequent fractures.
Hodsman
A B
AB
Osteoporosis Program, St. Joseph's Health Centre, London, Ontario.
D000368:Aged; D015519:Bone Density; D001862:Bone Resorption / Q000517:prevention & control; D001943:Breast Neoplasms / Q000150:complications*; D004965:Estrogen Antagonists / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D005260:Female; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000209:etiology / Q000517:prevention & control*; D015663:Osteoporosis, Postmenopausal / Q000209:etiology / Q000517:prevention & control
D004965:Estrogen Antagonists